Search Results

There are 16651 results for: content related to: Prevalent inhibitors in haemophilia B subjects enrolled in the U niversal D ata C ollection database

  1. US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors

    Haemophilia

    Volume 21, Issue 5, September 2015, Pages: 559–567, L. A. Valentino, C. L. Kempton, R. Kruse-Jarres, P. Mathew, S. L. Meeks, U. M. Reiss and on behalf of the International Immune Tolerance Induction Study Investigators

    Version of Record online : 2 JUN 2015, DOI: 10.1111/hae.12730

  2. Achievements, challenges and unmet needs for haemophilia patients with inhibitors

    Haemophilia

    Volume 22, Issue S1, January 2016, Pages: 1–24, Y. Dargaud, A. Pavlova, S. Lacroix-Desmazes, K. Fischer, M. Soucie, S. Claeyssens, D.w. Scott, R. d'Oiron, G. Lavigne-Lissalde, G. Kenet, C. Escuriola Ettingshausen, A. Borel-Derlon, T. Lambert, G. Pasta and C. Négrier

    Version of Record online : 5 JAN 2016, DOI: 10.1111/hae.12860

  3. You have free access to this content
    New predictive approaches for ITI treatment

    Haemophilia

    Volume 20, Issue s6, September 2014, Pages: 27–43, G. D. Minno, E. Santagostino, K. Pratt and C. Königs

    Version of Record online : 26 JUN 2014, DOI: 10.1111/hae.12467

  4. SURgical interventions with FEIBA (SURF): international registry of surgery in haemophilia patients with inhibitory antibodies

    Haemophilia

    Volume 19, Issue 3, May 2013, Pages: e143–e150, C. Négrier, A. Lienhart, R. Numerof, D. Stephens, W. Y. Wong, F. Baghaei and T. T. Yee

    Version of Record online : 3 JAN 2013, DOI: 10.1111/hae.12080

  5. Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials

    Haemophilia

    Volume 21, Issue 5, September 2015, Pages: e344–e358, A. O. Oladapo, J. D. Epstein, E. Williams, D. Ito, A. Gringeri and L. A. Valentino

    Version of Record online : 17 JUL 2015, DOI: 10.1111/hae.12759

  6. Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series

    Haemophilia

    Volume 23, Issue 2, March 2017, Pages: 255–263, A. Iorio, A. M. Barbara, M. Makris, K. Fischer, G. Castaman, C. Catarino, E. Gilman, K. Kavakli, T. Lambert, R. Lassila, T. Lissitchkov, E. Mauser-Bunschoten, M. E. Mingot-Castellano, N. Ozdemir, I. Pabinger, R. Parra, J. Pasi, K. Peerlinck, A. Rauch, V. Roussel-Robert, M. Serban, A. Tagliaferri, J. Windyga and E. Zanon

    Version of Record online : 15 FEB 2017, DOI: 10.1111/hae.13167

  7. The EPIC study: a lesson to learn

    Haemophilia

    Volume 21, Issue 5, September 2015, Pages: 622–628, G. Auerswald, K. Kurnik, L. M. Aledort, H. Chehadeh, A. Loew-Baselli, K. Steinitz, A. J. Reininger and forthe EPIC clinical study group

    Version of Record online : 23 APR 2015, DOI: 10.1111/hae.12666

  8. The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparison

    Haemophilia

    Volume 21, Issue 2, March 2015, Pages: 219–226, C. R. M. Hay, B. P. Palmer, E. A. Chalmers, D. P. Hart, R. Liesner, S. Rangarajan, K. Talks, M. Williams and P. W. Collins, on behalf ofUKHCDO

    Version of Record online : 7 NOV 2014, DOI: 10.1111/hae.12563

  9. You have free access to this content
    New findings on inhibitor development: from registries to clinical studies

    Haemophilia

    Volume 23, Issue S1, January 2017, Pages: 4–13, F. Peyvandi, C. E. Ettingshausen, J. Goudemand, V. Jiménez-Yuste, E. Santagostino and M. Makris

    Version of Record online : 19 DEC 2016, DOI: 10.1111/hae.13137

  10. You have full text access to this OnlineOpen article
    Recombinant B-domain-deleted porcine sequence factor VIII (r-pFVIII) for the treatment of bleeding in patients with congenital haemophilia A and inhibitors

    Haemophilia

    Volume 23, Issue 1, January 2017, Pages: 33–41, J. N. Mahlangu, T. A. Andreeva, D. E. Macfarlane, C. Walsh and N. S. Key

    Version of Record online : 20 OCT 2016, DOI: 10.1111/hae.13108

  11. Research in haemophilia B – approaching the request for high evidence levels in a rare disease

    Haemophilia

    Volume 21, Issue 1, January 2015, Pages: 4–20, K. Berger, D. Schopohl, A. Hilger, M. –E. Behr Gross, P. Giangrande, F. Peyvandi, R. Seitz and W. Schramm

    Version of Record online : 11 DEC 2014, DOI: 10.1111/hae.12603

  12. Severe and moderate haemophilia A and B in US females

    Haemophilia

    Volume 20, Issue 2, March 2014, Pages: e136–e143, D. M. Di Michele, C. Gibb, J. M. Lefkowitz, Q. Ni, L. M. Gerber and A. Ganguly

    Version of Record online : 18 FEB 2014, DOI: 10.1111/hae.12364

  13. Management of patients with long-term inhibitors: is immune tolerance an underestimated life-long solution?

    Haemophilia

    Volume 19, Issue s1, January 2013, Pages: 18–23, G. Di Minno and A. Coppola

    Version of Record online : 20 DEC 2012, DOI: 10.1111/hae.12052

  14. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients

    Haemophilia

    Volume 21, Issue 5, September 2015, Pages: 686–692, S. A. L. Montalvão, A. C. Tucunduva, L. H. Siqueira, A. L. A. Sambo, S. S. Medina and M. C. Ozelo

    Version of Record online : 24 FEB 2015, DOI: 10.1111/hae.12646

  15. Prevalence of clinical hip abnormalities in haemophilia A and B: an analysis of the UDC database

    Haemophilia

    Volume 19, Issue 3, May 2013, Pages: 426–431, D. Kelly, Q. C. Zhang, J. M. Soucie, M. Manco-Johnson, D. DiMichele and the Joint Outcome Subcommittee of the Coordinating Committee for the Universal Data Collection Database and the Hemophilia Treatment Center Network Investigators

    Version of Record online : 17 DEC 2012, DOI: 10.1111/hae.12073

  16. Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study

    Haemophilia

    Volume 21, Issue 5, September 2015, Pages: e369–e374, V. Rodriguez, M. E. Mancuso, D. Warad, C. R. M. Hay, D. M. DiMichele, L. Valentino, G. Kenet and R. Kulkarni

    Version of Record online : 14 JUL 2015, DOI: 10.1111/hae.12740

  17. Late immune tolerance induction in haemophilia A patients

    Haemophilia

    Volume 19, Issue 3, May 2013, Pages: 445–448, S. L. Meeks, R. L. Chapman, C. Kempton and A. L. Dunn

    Version of Record online : 7 JAN 2013, DOI: 10.1111/hae.12077

  18. You have free access to this content
    Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development

    Haemophilia

    Volume 20, Issue s6, September 2014, Pages: 2–16, P. M. Mannucci, Q. Shi, S. Bonanad and R. Klamroth

    Version of Record online : 26 JUN 2014, DOI: 10.1111/hae.12465

    Corrected by:

    Erratum: Erratum

    Vol. 20, Issue 5, e376, Version of Record online: 28 AUG 2014

  19. Multicentre, randomized, open-label study of on-demand treatment with two prophylaxis regimens of recombinant coagulation factor IX in haemophilia B subjects

    Haemophilia

    Volume 20, Issue 3, May 2014, Pages: 398–406, L. A. Valentino, L. Rusen, I. Elezovic, L. M. Smith, J. M. Korth-Bradley and P. Rendo

    Version of Record online : 13 JAN 2014, DOI: 10.1111/hae.12344

  20. You have free access to this content
    Inhibitors in haemophilia: what have we learned from registries? A systematic review

    Journal of Internal Medicine

    Volume 277, Issue 1, January 2015, Pages: 1–15, M. Osooli and E. Berntorp

    Version of Record online : 18 SEP 2014, DOI: 10.1111/joim.12301